In the second quarter of 2025, the world’s leading AI companies poured over $100 billion into data centers, compute infrastructure, and power systems. That’s not a typo. It’s a new normal. What’s unfolding isn’t just a generational tech wave—it’s a capital supercycle. And this one has metal behind it. At Eliakim Capital, we’re not watching this from the sidelines. We’re directly involved—brokering and advising on the infrastructure moves that are shaping this race: high-perfo

In the aftermath of one of Silicon Valley’s most infamous frauds, the biotech sector finds itself confronting an uncomfortable echo. Elizabeth Holmes—still serving time for the Theranos scandal—is once again adjacent to the world of health innovation. This time, it's through her partner, Billy Evans, who now leads a startup called Haemanthus. On paper, Hemanthus blends legitimate technologies: Raman spectroscopy and deep learning models aimed at fluid-based diagnostics. The i

The global private capital market faces a paradoxical challenge: a record $3.7 trillion in uninvested funds, commonly referred to as "capital overhang," remains on the sidelines, even as countless businesses seek capital to fuel growth and innovation. This disconnect between available capital and viable investment opportunities reflects the mounting pressures on private markets, exacerbated by macroeconomic headwinds and declining IPO activity. Here’s a closer look at the pro